Skip to main content
SpringerLink
Log in

Experimental immunoproliferative diseases

Models for immune responses and tumorigenesis

  • Guest Editorial Reviews
  • Published:
Survey of Immunologic Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Abbas, A.K.: Immunologic regulation of lymphoid tumor cells: model systems for lymphocyte function. Adv. Immunol.32: 301 (1982).

    Article  PubMed  CAS  Google Scholar 

  2. Lynch, R.G.; Rohrer, W.; Odermatt, B.; Gebel, H.; Autry, J.R.; Hoover, R.G.: Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation. Immunol. Rev.48: 45 (1979).

    Article  PubMed  CAS  Google Scholar 

  3. Abbas, A.K.; Perry, L.L.; Bach, B.A.; Greene, M.I.: Idiotype-specific T cell immunity. I. Generation of effector and suppressor T lymphocytes reactive with myeloma idiotypic determinants. J. Immun.124: 1160 (1980).

    PubMed  CAS  Google Scholar 

  4. Rohrer, J.W.; Vasa, K.; Lynch, R.G.: Myeloma cell immunoglobulin expression during in vivo growth in diffusion chambers: evidence for repetitive cycles of differentiation. J. Immun.119: 861 (1977).

    PubMed  CAS  Google Scholar 

  5. Parslow, T.G.; Milburn, G.L.; Lynch, R.G.; Granner, D.K.: Suppressor T cell action inhibits the expression of an excluded immunoglobulin gene. Science220: 1389 (1983).

    Article  PubMed  CAS  Google Scholar 

  6. Moser, G.; Tominaga, A.; Greene, M.I.; Abbas, A.K.: Accessory cells in immune suppression I. Role of I-A accessory cells in effector phase idiotype-specific suppression of myeloma function. J. Immun.131: 1728 (1983).

    PubMed  CAS  Google Scholar 

  7. Krolick, K.A.; Isakson, P.C.; Uhr, J.W.; Vitetta, E.S.: BCL1, a murine model for chronic lymphocytic leukemia: use of the surface immunoglobulin idiotype for the detection and treatment of tumor. Immunol. Rev.48: 81 (1979).

    Article  PubMed  CAS  Google Scholar 

  8. Hamblin, T.J.; Abdul-Ahad, A.K.; Gordon, J.; Stevenson, F.K.; Stevenson, G.T.: Preliminary experience in treating lymphocytic leukemia with antibody to immunoglobulin idiotypes on cell surfaces. Br. J. Cancer39: 434 (1980).

    Google Scholar 

  9. Lanier, L.; Babcock, G.; Raybourne, R.; Arnold, L.; Warner, N.; Haughton, G.: Mechanism of B cell lymphoma immunotherapy with passive xenogeneic antiidiotype serum. J. Immun.125: 1730 (1980).

    PubMed  CAS  Google Scholar 

  10. Glennie, M.J.; Stevenson, G.T.: Univalent antibodies kill tumor cells in vitro and in vivo. Nature, Lond.295: 712 (1982).

    Article  CAS  Google Scholar 

  11. Perek, Y.; Hurwith, E.; Burowski, D.; Haimovich, J.: Immunotherapy of a murine B cell tumor with antibodies and F(ab′)2 fragments against idiotypic determinants of its cell surface IgM. J. Immun.131: 1600(1983).

    PubMed  CAS  Google Scholar 

  12. Stevenson, F.K.; Gordon, J.: Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation. J. Immun.130: 970 (1983).

    PubMed  CAS  Google Scholar 

  13. Lynch, R.G.; Graff, R.J.; Sirisnha, S.; Simms, E.S.; Eisen, H.N.: Myeloma proteins as tumor-specific transplantation antigens. Proc. natn. Acad. Sci. USA69: 1540 (1972).

    Article  CAS  Google Scholar 

  14. Daley, M.J.; Gebel, H.M.; Lynch, R.G.: Idiotypespecific transplantation resistance to MOPC-315: abrogation by post-immunization thymectomy. J. Immun.120: 1620 (1978).

    PubMed  CAS  Google Scholar 

  15. Bridges, S.H.: Participation of the humoral immune system in myeloma-specific transplantation resistance. J. Immun.121: 479 (1978).

    PubMed  CAS  Google Scholar 

  16. Kresina, T.F.; Baine, Y.; Nisonoff, A.: Adoptive transfer of resistance to growth of an idiotype-secreting hybridoma by T cells from idiotypically suppressed mice. J. Immun.130: 478 (1983).

    Google Scholar 

  17. Slavin, S.; Weiss, L.; Morecki, S.; Weigensberg, M.: Eradication of murine leukemia with histoincompatible marrow grafts in mice conditioned with total lymphoid irradiation (TLI). Cancer Immunol. Immunother.11: 155 (1981).

    Article  Google Scholar 

  18. Weiss, L.; Morecki, S.; Vitetta, E.S.; Slavin, S.: Suppression and elimination of BLC1 leukemia by allogeneic bone marrow transplantation. J. Immun.130: 2452 (1983).

    PubMed  CAS  Google Scholar 

  19. Bortin, M.M.; Truitt, R.L.; Rimm, A.A.; Bach, F.H.: Graft-versus-leukemia reactivity induced by alloimmunization without augmentation of graft-versus-host reactivity. Nature, Lond.281: 490 (1979).

    Article  CAS  Google Scholar 

  20. Bortin, M.M.; Truitt, R.L.; Shih, C.Y.; Rimm, A.A.: Induction of reactivity against murine leukemia in MHC compatible donors; in Okunewick, Meredith, Graft-versus-leukemia in man and animal models, pp. 139–156 (CRC Press, Boca Raton 1981).

    Google Scholar 

  21. Truitt, R.L.; Shih, C.Y.; Lefever, A.V.; Tempelis, L.D.; Andreani, M.; Bortin, M.M.: Characterization of alloimmunization-induced T lymphocytes with graft-versus-leukemia activity in vivo. J. Immun.131: 2050 (1983).

    PubMed  CAS  Google Scholar 

  22. Badger, C.C.; Bernstein, I.D.: Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen. J. exp. Med.157: 828 (1983).

    Article  PubMed  CAS  Google Scholar 

  23. Bernstein, I.D.; Nowinski, R.C.; Tarn, M.R.; McMaster, B.; Houston, I.L.; Clark, E.A.: Monoclonal antibody therapy of mouse leukemia; in Kennett, McKearn, Bechtol, Monoclonal antibodies, pp. 275–291 (Plenum Press, New York 1980).

    Google Scholar 

  24. Sharkey, F.E.; Fogh, J.: Incidence and pathological features of spontaneous tumors in athymic nude mice. Cancer Res.39: 833 (1979).

    PubMed  CAS  Google Scholar 

  25. Beattie, G.; Baird, S.; Lannom, R.; Slimmer, S.; Jenson, F.C.; Kaplan, N.O.: Induction of lymphoma in athymic mice: a model for study of the human disease. Proc. natn. Acad. Sci. USA77: 4971 (1980).

    Article  CAS  Google Scholar 

  26. Baird, S.M.; Beattie, G.M.; Lannom, R.A.; Lipsick, J.S.; Jenson, F.C.; Kaplan, N.O.: Induction of lymphoma in antigenically stimulated athymic mice. Cancer Res.42: 198 (1982).

    PubMed  CAS  Google Scholar 

  27. Gershwin, M.E.; Ohsugi, Y.; Castles, J.J.; Ikeda, R.M.; Reubner, B.: Anti-μ induces lymphoma in germ-free congenitally athymic (nude) but not in heterozygous (nu/+) mice. J. Immun.131: 2039 (1983).

    Google Scholar 

  28. Arnold, L.W.; Locascio, N.J.; Lutz, P.M.; Pennell, C.A.; Klapper, D.; Haughton, G.: Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity. J. Immun.131: 2064 (1983).

    PubMed  CAS  Google Scholar 

  29. Stanton, L.W.; Watt, R.; Marcu, K.B.: Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas. Nature, L?nd.303: 401 (1983).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pathology, Brigham and Women’s Hospital and Harvard Medical School, 02115, Boston, MA, USA

    S. David Hudnall

Authors
  1. S. David Hudnall
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

David Hudnall, S. Experimental immunoproliferative diseases. Surv. immunol. Res. 3, 259–263 (1984). https://doi.org/10.1007/BF02919041

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02919041

Keywords

Search

Navigation